Gabapentin and Taxol drug interactions for women aged 60+ (a phase IV clinical study of FDA data)

Summary:

Drug interactions are found for women aged 60+ who take Gabapentin (gabapentin) and Taxol (paclitaxel) together. We list drug interactions by the duration when the drugs are taken. This phase IV study is created by eHealthMe based on reports of 110 people from the FDA, and is updated regularly.



On Jun, 15, 2026

110 women aged 60+ who take Gabapentin, Taxol and have drug interactions are studied.


What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,981 Gabapentin users. Check the latest studies of Gabapentin.

What is Taxol?

Taxol has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 33,554 Taxol users. Check the latest studies of Taxol.

Number of reports submitted per year:

Gabapentin and Taxol drug interactions in women aged 60+.

Most common drug interactions over time *:

< 1 month:

  1. Diarrhoea
  2. Neuropathy peripheral (surface nerve damage)
  3. Anaemia (lack of blood)
  4. Decreased appetite
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  7. Hip fracture
  8. Pyrexia (fever)
  9. Skin infection
  10. Stomatitis (inflammation of mucous membrane of mouth)

1 - 6 months:

  1. Hip fracture
  2. Hyperglycaemia (high blood sugar)
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Hypertension (high blood pressure)
  5. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  6. Insomnia (sleeplessness)
  7. Lacrimation increased
  8. Metastasis (spreadable cancer to other organ from origin)
  9. Mucosal inflammation (infection of mucous membrane)
  10. Multiple fractures

6 - 12 months:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Aspartate aminotransferase increased
  3. Blood alkaline phosphatase increased
  4. Blood bilirubin increased
  5. Diarrhoea
  6. Epigastric discomfort
  7. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  8. Nail infection
  9. Neuropathy peripheral (surface nerve damage)
  10. Neutropenia (an abnormally low number of neutrophils)

1 - 2 years:

n/a

2 - 5 years:

  1. Alopecia (absence of hair from areas of the body)
  2. Hair colour changes
  3. Hair disorder

5 - 10 years:

  1. Alopecia (absence of hair from areas of the body)
  2. Hair colour changes
  3. Suicidal ideation
  4. Weight increased
  5. Hair disorder
  6. Depressed mood
  7. Drug dependence
  8. Drug ineffective
  9. Dry mouth
  10. Malaise (a feeling of general discomfort or uneasiness)

10+ years:

n/a

not specified:

  1. Alopecia (absence of hair from areas of the body)
  2. Pyrexia (fever)
  3. Decreased appetite
  4. Diarrhoea
  5. Cough
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Hypokalaemia (low potassium)
  8. Asthenia (weakness)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Neuropathy peripheral (surface nerve damage)

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Taxol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related publications that referenced our studies:

Related studies:

How the study uses the data?

The study is based on (applicable) gender, age, gabapentin and paclitaxel (the active ingredients of Gabapentin and Taxol, respectively), and Gabapentin and Taxol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: